Leaflet REMAVIR 50mg tablets
Indicated for: viral infections
Route of administration: oral
Substance: rimantadine (antiviral)
ATC: J05AC02 (Antiinfectives for systemic use | Direct acting antivirals | Cyclic amines)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Rimantadine is an antiviral medication used for the prevention and treatment of infections caused by influenza A virus. It works by inhibiting viral replication, reducing the severity and duration of symptoms.
The medication is taken orally, as directed by a doctor, usually once or twice daily. It is important for patients to start treatment as soon as possible after symptom onset to achieve maximum effectiveness.
Patients should be aware of potential side effects, such as nausea, dizziness, or insomnia. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, dizziness, and insomnia. In rare cases, severe reactions such as allergic reactions or neurological disturbances may occur. Patients should be informed of these risks before starting treatment.
General data about REMAVIR 50mg
- Substance: rimantadine
- Date of latest medicines list: 16-08-2017
- Product code: W63703001
- Concentration: 50mg
- Pharmaceutical form: tablets
- Quantity: 20
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.